NSC |
Compound |
Enrichment |
Correlation |
NSC 622124 |
Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) |
0.0228801759885687 |
0.061090808 |
NSC 626390 |
Null |
0.0228801759885687 |
0.61570998 |
NSC 654509 |
Pirarubicin HCl |
0.0228801759885687 |
-0.046138531 |
NSC 666112 |
Null |
0.0228801759885687 |
-0.1440681 |
NSC 677696 |
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester |
0.0228801759885687 |
0.022257826 |
NSC 677921 |
Null |
0.0228801759885687 |
0.069484739 |
NSC 703037 |
Null |
0.0228801759885687 |
0.47755169 |
NSC 708423 |
Null |
0.0228801759885687 |
-0.40499191 |
NSC 727087 |
16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate |
0.0228801759885687 |
-0.245074 |
NSC 740 |
Methotrexate |
0.0228801759885687 |
-0.24897052 |